BjordalJM, JohnsonMI, IversenV, AimbireF, Lopes-MartinsRA. Low-level laser therapy in acute pain: a systematic review of possible mechanisms of action and clinical effects in randomized placebo-controlled trials. Photomed Laser Surg, 2006; 24:158–168.
2.
HashmiJT, HuangYY, SharmaSK, et al.Effect of pulsing in low-level light therapy. Lasers Surg Med, 2010; 42:450–466.
3.
OronU, YaakobiT, OronA, et al.Low-energy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs. Circulation, 2001; 103:296–301.
4.
RizziCF, MaurizJL, Freitas CorreaDS, et al.Effects of low-level laser therapy (LLLT) on the nuclear factor (NF)-kappaB signaling pathway in traumatized muscle. Lasers Surg Med, 2006; 38:704–713.
5.
BaroletD, BoucherA. Prophylactic low-level light therapy for the treatment of hypertrophic scars and keloids: a case series. Lasers Surg Med, 2010; 42:597–601.
MeneguzzoDT, LopesLA, PallotaR, Soares–FerreiraL, Lopes–MartinsRA, RibeiroMS. Prevention and treatment of mice paw edema by near-infrared low-level laser therapy on lymph nodes. Lasers Med Sci, 2013; 28:973–980.
8.
LuoL, SunZ, ZhangL, LiX, DongY, LiuTC. Effects of low-level laser therapy on ROS homeostasis and expression of IGF-1 and TGF-beta1 in skeletal muscle during the repair process. Lasers Med Sci, 2013; 28:725–734.
9.
BjordalJM, CouppeC, ChowRT, TunerJ, LjunggrenEA. A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Aust J Physiother, 2003; 49:107–116.
10.
ChowRT, JohnsonMI, Lopes–MartinsRA, BjordalJM. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. Lancet, 2009; 374:1897–1908.
11.
ChowR, ArmatiP, LaaksoEL, BjordalJM, BaxterGD. Inhibitory effects of laser irradiation on peripheral mammalian nerves and relevance to analgesic effects: a systematic review. Photomed Laser Surg, 2011; 29:365–381.
12.
SongS, ZhouF, ChenWR. Low-level laser therapy regulates microglial function through Src-mediated signaling pathways: implications for neurodegenerative diseases. J Neuroinflammation, 2012; 9:219.
13.
HuangYY, GuptaA, VecchioD, et al.Transcranial low level laser (light) therapy for traumatic brain injury. J Biophotonics, 2012; 5:827–837.
14.
KaruTI.Multiple roles of cytochrome c oxidase in mammalian cells under action of red and IR–A radiation. IUBMBLife, 2010; 62:607–610.
15.
MurrellGA, FrancisMJ, BromleyL. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J, 1990; 265:659–665.
16.
AntunesF, BoverisA, CadenasE.On the mechanism and biology of cytochrome oxidase inhibition by nitric oxide. Proc Natl Acad Sci USA, 2004; 101:16,774–16,779.
17.
ChungH, DaiT, SharmaSK, HuangYY, CarrollJD, HamblinMR. The nuts and bolts of low–level laser (light) therapy. Ann Biomed Eng, 2012; 40:516–533.
18.
KaruTI, KolyakovSF. Exact action spectra for cellular responses relevant to phototherapy. PhotomedLaser Surg, 2005; 23:355–361.
19.
KaruT.Photobiology of low-power laser effects. Health Phys, 1989; 56:691–704.
20.
AssisL, MorettiAI, AbrahaoTB, et al.Low-level laser therapy (808 nm) reduces inflammatory response and oxidative stress in rat tibialis anterior muscle after cryolesion. Lasers Surg Med, 2012; 44:726–735.
21.
KaruTI, PyatibratLV, KalendoGS. Photobiological modulation of cell attachment via cytochrome c oxidase. Photochem Photobiol Sci, 2004; 3:211–216.
22.
FujimakiY, ShimoyamaT, LiuQ, UmedaT, NakajiS, SugawaraK. Low-level laser irradiation attenuates production of reactive oxygen species by human neutrophils. J Clin Laser Med Surg, 2003; 21:165–170.
23.
SilveiraPC, da SilvaLA, PinhoCA, et al.Effects of low-level laser therapy (GaAs) in an animal model of muscular damage induced by trauma. Lasers Med Sci, 2013; 28:431–436.
24.
de LimaFM, VillaverdeAB, AlbertiniR, et al.Dual effect of low-level laser therapy (LLLT) on the acute lung inflammation induced by intestinal ischemia and reperfusion: action on anti- and pro-inflammatory cytokines. Lasers Surg Med, 2011; 43:410–420.
25.
LohrNL, KeszlerA, PrattP, BienengraberM, WarltierDC, HoggN. Enhancement of nitric oxide release from nitrosyl hemoglobin and nitrosyl myoglobin by red/near infrared radiation: potential role in cardioprotection. J Mol Cell Cardiol, 2009; 47:256–263.
26.
LopesNN, PlaplerH, ChavantesMC, LallaRV, YoshimuraEM, AlvesMT. Cyclooxygenase-2 and vascular endothelial growth factor expression in 5-fluorouracil-induced oral mucositis in hamsters: evaluation of two low-intensity laser protocols. Support Care Cancer, 2009; 17:1409–1415.
27.
LopesNN, PlaplerH, LallaRV, et al.Effects of low-level laser therapy on collagen expression and neutrophil infiltrate in 5-fluorouracil-induced oral mucositis in hamsters. Lasers Surg Med, 2010; 42:546–552.
28.
MendenhallWM, ParsonsJT, BuattiJM, et al.Advances in radiotherapy for head and neck cancer. Semin Surg Oncol, 1995; 11:256–264.
29.
ManciniML, SonisST. Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities. Front Pharmacol, 2014; 5:51.
30.
FillipinLI, MaurizJL, VedovelliK, et al.Low-level laser therapy (LLLT) prevents oxidative stress and reduces fibrosis in rat traumatized Achilles tendon. Lasers Surg Med, 2005; 37:293–300.
31.
Lev-TovH, BrodyN, SiegelD, JagdeoJ. Inhibition of fibroblast proliferation in vitro using low-level infrared light-emitting diodes. Dermatol Surg, 2013; 39:422–425.
EltingLS, KeefeDM, SonisST, et al.Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life. Cancer, 2008; 113:2704–2713.
34.
SonisST.A biological approach to mucositis. J Support Oncol, 2004; 2:21–32.
35.
Al-DasooqiN, SonisST, BowenJM, BatemanE, BlijlevensN, GibsonRJ, LoganRM, NairRG, StringerAM, YazbeckR, EladS, LallaRV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Emerging evidence on the pathobiology of mucositis. Support Care Cancer, 2013; Nov; 21(11):3233–3241.
36.
LallaRV, BowenJ, BaraschA, et al.MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 2014; 120:1453–1461.
37.
ClarksonJE, WorthingtonHV, FurnessS, McCabeM, KhalidT, MeyerS. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev, 2010; 8:CD001973.
38.
BjordalJM, BensadounRJ, TunerJ, FrigoL, GjerdeK, Lopes–MartinsRA. A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis. Support Care Cancer, 2011; 19:1069–1077.
39.
BensadounRJ, NairRG. Low-level laser therapy in the prevention and treatment of cancer therapy-induced mucositis: 2012 state of the art based on literature review and meta-analysis. Curr Opin Oncol, 2012; 24:363–370.
40.
BernierJ, BonnerJ, VermorkenJB, et al.Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol, 2008; 19:142–149.
41.
MartinM, LefaixJ, DelanianS. TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?. Int J Radiat Oncol Biol Phys, 2000; 47:277–290.
AvciP, GuptaA, SadasivamM, et al.Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg, 2013; 32:41–52.
44.
CostaMM, SilvaSB, QuintoAL, et al.Phototherapy 660 nm for the prevention of radiodermatitis in breast cancer patients receiving radiation therapy: study protocol for a randomized controlled trial. Trials, 2014; 15:330.
45.
DeLandMM, WeissRA, McDanielDH, GeronemusRG. Treatment of radiation-induced dermatitis with light-emitting diode (LED) photomodulation. Lasers Surg Med, 2007; 39:164–168.
46.
FifeD, RayhanDJ, BehnamS, et al.A randomized, controlled, double-blind study of light emitting diode photomodulation for the prevention of radiation dermatitis in patients with breast cancer. Dermatol Surg, 2010; 36:1921–1927.
